Sat.Dec 24, 2022 - Fri.Dec 30, 2022

article thumbnail

New tentative approval for Teva Pharms drug eltrombopag

Drug Patent Watch

[![eltrombopag structure]([link] Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting this compound. There are four….

article thumbnail

FDA approval of Biogen Alzheimer’s drug was ‘rife with irregularities,’ congressional report says

Bio Pharma Dive

An investigation by two House committees concluded the FDA failed to document all its meetings with Biogen, and shifted to consider an accelerated clearance on a “substantially abbreviated timeline &rdquo

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Looking back at 2022: The top healthcare stories

Pharmaceutical Technology

The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions.

article thumbnail

Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report

Fierce Pharma

Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report. aarmstrong. Thu, 12/29/2022 - 14:42

104
104
article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

New patent expiration for Novo Nordisk drug VICTOZA

Drug Patent Watch

Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are seven…. The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Pfizer says hemophilia B gene therapy controlled bleeding in key study

Bio Pharma Dive

The Phase 3 results showed the one-time treatment outperformed standard factor replacement in adults with the bleeding disorder, but suggest it may be less potent than CSL and UniQure’s rival therapy

More Trending

article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

Pharma Phorum

This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves.

article thumbnail

Exploring the Digital Therapeutics Landscape

Pharmaceutical Commerce

Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton.

65
article thumbnail

After FDA's Ukoniq pull, TG Therapeutics wins commercial mulligan with Briumvi to enter crowded MS arena

Fierce Pharma

After FDA's Ukoniq pull, TG Therapeutics wins commercial mulligan with Briumvi to enter crowded MS arena. fkansteiner. Thu, 12/29/2022 - 09:30

83
article thumbnail

Revenue for Inotersen sodium by Swedish Orphan Biovitrum is expected to have a CAGR of -30.16% through 2030. How does that impact the rNPV of the drug?

Pharmaceutical Technology

Inotersen sodium is a Antisense Oligonucleotide owned by Akcea Therapeutics, and is involved in 9 clinical trials, of which 5 were completed, and 4 are ongoing. ISIS-TTRRx is a transthyretin (TTR) protein inhibitor. Normal and mutant forms of TTR progressively accumulate in tissues in transthyretin amyloidosis hence impairing the tissue function.

Protein 156
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

Pharma manufacturing can digitalise its way round the next crisis

Pharma Phorum

The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis.

article thumbnail

New patent for Epi Hlth drug RHOFADE

Drug Patent Watch

Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Epi Hlth and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Epi Hlth drug RHOFADE appeared first on DrugPatentWatch - Make Better Decisions. Patent Added

article thumbnail

Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma

Fierce Pharma

Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma. kdunleavy. Tue, 12/27/2022 - 09:16

article thumbnail

As Panobinostat moves closer to clinical approval for additional indication, what is the likelihood that the drug will be approved?

Pharmaceutical Technology

Panobinostat is under clinical development by Secura Bio and currently in the Phase I and Phase II in clinical pathway.

Hormones 130
article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

Bring point of care testing to the community for a preventative, cost effective, Net Zero NHS

Pharma Phorum

The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new survey of 200 GPs in the UK.

Nurses 83
article thumbnail

People Spotlight — December 2022

Pharmaceutical Commerce

The latest people news happenings over the past month.

52
article thumbnail

What are the Vital Advantages Offered by PCD Pharma Companies?

Fossil Remedies

Since the pharma sector has performed remarkably well in the fast few decades and the future is also showing very good signs, it is quite natural that more and more people are entering the arena. There are many types of pharma businesses and one can choose any of them.

article thumbnail

Tecarfarin sodium, what is the likelihood that the drug will be approved?

Pharmaceutical Technology

Tecarfarin sodium is under clinical development by Cadrenal Therapeutics and currently in the Phase III in clinical pathway.

article thumbnail

Is the proposed Data Protection and Digital Information Bill fit for purpose?

Pharma Phorum

A new Data Protection and Digital Information Bill is currently being considered by UK ministers.

article thumbnail

New tentative approval for Teva Pharms drug eltrombopag

Drug Patent Watch

[![eltrombopag structure]([link] Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting this compound. There are four….

article thumbnail

Berkshire Sterile Further Grows Its Instrument Collection

Pharmaceutical Commerce

With the new additions, CDMO expands its analytical testing and development services.

article thumbnail

Japan’s MHLW approves AstraZeneca’s Imfinzi, Imjudo for liver, lung cancers

Pharmaceutical Technology

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved AstraZeneca ’s immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) to treat advanced liver, biliary tract, and lung cancers.

Protein 130
article thumbnail

How medical device sales teams can embrace digital transformation

Pharma Phorum

Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process.

Sales 83
article thumbnail

New tentative approval for Amneal Pharms drug saxagliptin

Drug Patent Watch

[![saxagliptin structure]([link] Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents protecting this compound. There are….

article thumbnail

Benefits of Structured Content in Preparing Data for Regulatory Submissions

Pharmaceutical Commerce

How taking steps to incorporate data into all regulatory and labeling operations helps firms avoid retroactively planning to recapture information.

52
article thumbnail

Gilead Sciences to buy all rights of GS-1811 from Jounce

Pharmaceutical Technology

Gilead Sciences and Jounce Therapeutics have amended their current license agreement for first-in-class immunotherapy, GS-1811 (formerly JTX-1811). The initial license agreement was signed in 2020.

Licensing 130
article thumbnail

Gilead grabs full rights to Jounce cancer immunotherapy

Pharma Phorum

Gilead Sciences must like what it has seen in a two-year-old partnership with Jounce Therapeutics for a CCR8-targeting cancer immunotherapy – it has just agreed to take full ownership of the programme.

article thumbnail

New patent for Azurity drug ZONISADE

Drug Patent Watch

Annual Drug Patent Expirations for ZONISADE Zonisade is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There is one patent protecting…. The post New patent for Azurity drug ZONISADE appeared first on DrugPatentWatch - Make Better Decisions. Patent Added

article thumbnail

4 Life Sciences Trends for 2023

XTalks

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic.

article thumbnail

2022 in Review: Tracking the ups and downs of pharma deals

Pharmaceutical Technology

This year, volatility resulting from the Russian war on Ukraine, residual uncertainty from the Covid-19 pandemic, and more led to fluctuating dynamics in the pharmaceutical space.

article thumbnail

Upholding regulatory compliance in decentralised trials

Pharma Phorum

Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT model need to keep in mind that it is not a one-size-fits-all approach.

article thumbnail

New patent for HANDA drug TASCENSO ODT

Drug Patent Watch

Annual Drug Patent Expirations for TASCENSO+ODT Tascenso Odt is a drug marketed by Handa and is included in one NDA. There are three patents protecting this drug. This drug has…. The post New patent for HANDA drug TASCENSO ODT appeared first on DrugPatentWatch - Make Better Decisions. Patent Added

article thumbnail

UCB's bimekizumab finally back on the FDA's review list after May rejection

Fierce Pharma

UCB's bimekizumab finally back on the FDA's review list after May rejection. zbecker. Wed, 12/28/2022 - 11:17

52
article thumbnail

LegoChem, Amgen partner to develop antibody drug conjugates

Pharmaceutical Technology

LegoChem Biosciences and Amgen have signed a multi-target research collaboration and license agreement to develop antibody-drug conjugates (ADC).

Antibody 130